Cosmetic Science Biotech Co., Ltd. (1786) Announces Q4 2025 Financial Results
NQ Score
57/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Cosmetic Science Biotech Co., Ltd. (1786) reported its operating results for the fourth quarter of 2025. The company announced a basic earnings per share (EPS) of NT$2.24 for the quarter. Revenue reached NT$887 million, with a net profit after tax of NT$162 million. Cosmetic Science Biotech operates within the biotechnology and medical industry.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What were Cosmetic Science Biotech's Q4 2025 earnings per share?
- A: Cosmetic Science Biotech's basic earnings per share for Q4 2025 was NT$2.24.
- Q: What was the company's revenue in the fourth quarter of 2025?
- A: The company's operating revenue for Q4 2025 was NT$887 million.
- Q: What was the net profit after tax for Cosmetic Science Biotech in Q4 2025?
- A: The net profit after tax for Q4 2025 was NT$162 million.